US Patent 10052386 Progesterone formulations
Patent 10052386 was granted and assigned to TherapeuticsMD on August, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10052386 Progesterone formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.